Pegylated liposomal doxorubicin treatment in patients with refractory or relapsed central nervous system (CNS) lymphoma.

被引：0

作者：

Calvisi, A ^{[1
]}

Palmas, AD ^{[1
]}

Lai, P ^{[1
]}

Bianchi, A ^{[1
]}

Murgia, A ^{[1
]}

Gaviano, E ^{[1
]}

Noli, AL ^{[1
]}

Curreli, L ^{[1
]}

Gabbas, A ^{[1
]}

机构：

[1] San Francisco Hosp, Hematol & BMT Ctr, Nuoro, Italy

来源：

BLOOD | 2002年 / 100卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4750

引用

页码：302B / 303B

页数：2

共 50 条

[11] Gemcitabine, Vinorelbine and Pegylated Liposomal Doxorubicin (GVD) in the Treatment of Relapsed or Refractory Hodgkin's Lymphoma - Experience of a Portuguese Center
Queiroz, Luisa Vilaca
Fidalgo, Paula
Moreira, Claudia
Ilda, Faustino
Pantarotto, Marcos
Ferreira, Marta
Lombo, Liliana
Pereira, Dulcineia
Pina, Idilia
Mariano, Monica
Rodrigues, Angelo
Santo, Ana Espirito
Martins, Angelo
Moreira, Ilidia
Oliveira, Isabel
Marques, Margarida
Viterbo, Luisa
Domingues, Nelson
Mariz, Jose Mario
[J]. BLOOD, 2012, 120 (21)
[12] Preliminary Exploration of Ibrutinib Combined with Methotrexate, Ifosfamide, Liposomal Doxorubicin and Methylprednisolone in the Treatment of Relapsed/Refractory Primary CNS Lymphoma
Chen Yuedan
Sun, Xuefei
Bai, Xueyan
Cui, Qu
Xing, Ruixian
Liu, Yuanbo
[J]. BLOOD, 2020, 136
[13] Safety and efficacy of pegylated liposomal doxorubicin for the treatment of advanced cutaneous T-cell lymphoma.
Rupoli, S
Tassetti, A
Pulini, S
Offidani, M
Scortechini, AR
Giangiacomi, M
Barulli, S
Mozzicafreddo, G
Giacchetti, A
Ricotti, G
Brandozzi, G
Simonacci, M
Alterini, R
Pimpinelli, N
Leoni, P
[J]. BLOOD, 2003, 102 (11) : 289B - 289B
[14] A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML
Jonas, Brian A.
Potter, Laura A.
Galkin, Maria
Tuscano, Joseph M.
[J]. LEUKEMIA RESEARCH REPORTS, 2023, 19
[15] Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma
Cohen, Alexa
Spektor, Tanya M.
Stampleman, Laura
Bessudo, Alberto
Rosen, Peter J.
Klein, Leonard M.
Woliver, Thomas
Flam, Marshall
Eshaghian, Shahrooz
Nassir, Youram
Maluso, Tina
Swift, Regina A.
Vescio, Robert
Berenson, James R.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (01) : 60 - 70
[16] Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients
Romano, Alessandra
Chiarenza, Annalisa
Conticello, Concetta
Cavalli, Maide
Vetro, Calogero
Di Raimondo, Cosimo
Cunsolo, Rosario
Palumbo, Giuseppe Alberto
Di Raimondo, Francesco
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (03) : 207 - 213
[17] Role of Pegylated Liposomal Doxorubicin in Heavily Pretreated Relapsed Refractory Hodgkin Lymphoma Eligible for Autologous or Allogeneic Transplantation
Casadei, Beatrice
Pellegrini, Cinzia
Sutto, Emanuele
Cantelli, Martina
Argnani, Lisa
Zoli, Sabrina
Coppola, Paolo Elia
Gentilini, Marianna
Morigi, Alice
Carella, Matteo
Gugliotta, Gabriele
Bagnato, Gianmarco
Nanni, Laura
Broccoli, Alessandro
Stefoni, Vittorio
Zinzani, Pier Luigi
[J]. BLOOD, 2023, 142
[18] Successful treatment in primary central nervous system lymphoma.
Atilla, Erden
Ataca, Pinar
Toprak, Selami Kocak
Yuksel, Meltem Kurt
Topcuoglu, Pervin
Ilhan, Osman
Gurman, Gunhan
Ozcan, Muhit
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[19] Zanubrutinib plus Cytarabine in Patients with Refractory/Relapsed Primary Central Nervous System Lymphoma
Lin, Zhiguang
Ma, Jingjing
Ma, Yan
Li, Qing
Kang, Hui
Zhang, Mengxue
Chen, Bobin
[J]. ACTA HAEMATOLOGICA, 2024,
[20] Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia
Yao, Han
Zhang, Cheng
Tan, Xu
Li, Jieping
Yin, Xiaolin
Deng, Xiaojuan
Chen, Ting
Rao, Jun
Gao, Lei
Kong, Peiyan
Zhang, Xi
[J]. CANCER MEDICINE, 2023, 12 (11): : 12377 - 12387

← 1 2 3 4 5 →